335 related articles for article (PubMed ID: 24403841)
1. Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients.
Tessari A; Palmieri D; Di Cosimo S
Pharmgenomics Pers Med; 2013 Dec; 7():1-19. PubMed ID: 24403841
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
Beigh MM
Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
[TBL] [Abstract][Full Text] [Related]
7. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
8. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
[TBL] [Abstract][Full Text] [Related]
11. Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.
Kelly CM; Buzdar AU
Drugs; 2013 May; 73(6):505-15. PubMed ID: 23605692
[TBL] [Abstract][Full Text] [Related]
12. Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials.
Verlingue L; Alt M; Kamal M; Sablin MP; Zoubir M; Bousetta N; Pierga JY; Servant N; Paoletti X; Le Tourneau C
Per Med; 2014 Jul; 11(5):545-558. PubMed ID: 29758779
[TBL] [Abstract][Full Text] [Related]
13. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
[TBL] [Abstract][Full Text] [Related]
14. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized Medicine.
Rosa M
Cancer Control; 2015 Apr; 22(2):211-9. PubMed ID: 26068767
[TBL] [Abstract][Full Text] [Related]
16. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
[TBL] [Abstract][Full Text] [Related]
17. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
[TBL] [Abstract][Full Text] [Related]
19. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]